Article
The homogeneous mutation status of a 22 gene panel justifies the use of serial sections of colorectal cancer tissue for external quality assessment.
Virchows Archiv : an international journal of pathology - 1 Sept 2015
Dijkstra Jeroen R, Tops Bastiaan B J, Nagtegaal Iris D, van Krieken J Han J M, Ligtenberg Marjolijn J L
Abstract excerpt
Testing for treatment related biomarkers in clinical care, like Ras mutation status in colorectal cancer (CRC), has increased drastically over recent years. Reliable testing of these markers is pivotal for optimal treatment of patients. Participation in external quality assessment (EQA) programs is an important element in quality management and often obligatory to comply with regulations or for accreditation....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
